Use of the Nonsteroidal Anti-androgen Casodex in Advanced Prostatic Carcinoma-Reference-Cited by-同舟云学术

Use of the Nonsteroidal Anti-androgen Casodex in Advanced Prostatic Carcinoma

Published:1991-02 Issue:1 Volume:18 Page:99-110
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Kennealey Gerard T.,Furr Barrington J.A.

Publisher

Elsevier BV

Subject

Urology

Reference43 articles.

1. Preliminary report on the use of formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer;Ahmed;Br Med J,1985

2. Cancer facts and figures—1990;American Cancer Society,1990

3. Ocular toxicity of Anandron;Brisset;Br J Ophthalmol,1987

4. Total androgen blockade in advanced prostate carcinoma: Interim report of a double blind study using Zoladex and flutamide [abstract];Cariou;J Urol,1990

5. Patient choice of treatment in stage D prostate cancer;Cassileth;Urology,1989

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen Receptor;Journal of Chemical Information and Modeling;2016-11-18

2. Management of Newly Diagnosed Metastatic Disease;Management of Prostate Cancer;2012

3. Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer;Bioorganic & Medicinal Chemistry;2010-12

4. Structure–activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists;Bioorganic & Medicinal Chemistry;2010-05

5. Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit;Journal of Medicinal Chemistry;2009-05-11